Dynamic Global Events (“DGE”) recently hosted the Investigator-Initiated Trials (“IIT”) Conference, gathering industry experts, clinical investigators and research professionals for an immersive two-day event focused on advancing investigator-initiated trials. This year’s event provided an in-depth look into the challenges, best practices and regulatory considerations essential to optimizing IIT processes in today’s rapidly evolving clinical research landscape.
Highlights from the Conference
The IIT Conference featured a dynamic lineup of speakers who shared their insights on topics critical to the success of IITs, including trial design, funding strategies and operational efficiency. Speakers from leading pharmaceutical companies, academic institutions and research organizations brought valuable perspectives to share with the audience.
Key sessions included:
- Uncover “Best Practices” While Building a Successful IIT
- Strategize the Best Way to Generate KPIs from Your IIT
- Forecast Budget Needs to Set Yourself Up for Success
- Map out Regulatory and Compliance Challenges Globally
- Enhance Communication between Investigators and Sponsors
Networking and Collaboration
Beyond the formal sessions, the conference provided ample networking opportunities, allowing attendees to connect and exchange ideas. The event’s interactive format encouraged meaningful dialogue, enabling participants to deepen their understanding of IITs and develop new strategies for their own work.
Looking Forward
The Investigator-Initiated Trials Conference uncovered the essential role of investigator-led studies in advancing medical knowledge and delivering impactful patient outcomes. Dynamic Global Events would like to extend a special thank you to all speakers and participants who made this event a success. We look forward to continuing to support the growth and innovation of IITs and hope to see you all at our upcoming events!
View DGE’s 2025 conference calendar.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN